Hot topics close

Insiders At Johnson & Johnson Sold US$6.8m In Stock, Alluding To Potential Weakness

Insiders At Johnson  Johnson Sold US68m In Stock Alluding To Potential 
Weakness
Over the past year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a significant stake in the company which may have...

Over the past year, many Johnson & Johnson (NYSE:JNJ) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Check out our latest analysis for Johnson & Johnson

Johnson & Johnson Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the Executive VP & Chief Human Resources Officer, Peter Fasolo, for US$3.4m worth of shares, at about US$170 per share. That means that an insider was selling shares at around the current price of US$158. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

In the last year Johnson & Johnson insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume

insider-trading-volume

I will like Johnson & Johnson better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Insiders At Johnson & Johnson Have Sold Stock Recently

The last three months saw significant insider selling at Johnson & Johnson. In total, insider Vanessa Broadhurst dumped US$1.4m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

Story continues

Insider Ownership Of Johnson & Johnson

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Johnson & Johnson insiders own about US$286m worth of shares (which is 0.07% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Do The Johnson & Johnson Insider Transactions Indicate?

An insider sold stock recently, but they haven't been buying. Looking to the last twelve months, our data doesn't show any insider buying. It is good to see high insider ownership, but the insider selling leaves us cautious. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. In terms of investment risks, we've identified 2 warning signs with Johnson & Johnson and understanding these should be part of your investment process.

Of course Johnson & Johnson may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Similar news
News Archive
  • Cancer vaccine
    Cancer vaccine
    Personalized Cancer Vaccines Market : Size, Outlook, Geographical Segmentation, Business Challenges and ...
    12 Sep 2023
    5
  • Sanofi Pasteur
    Sanofi Pasteur
    Conjugate Vaccines Market Quality & Quantity Analysis | CSL Limited, Sanofi Pasteur, Astellas Pharma Inc
    7 Oct 2021
    2
  • Gymshark
    Gymshark
    No gatekeeping! Gymshark's summer sale has kicked off and there's ...
    27 Jun 2024
    11
  • Voicedirected warehousing
    Voice-directed warehousing
    Voice-Directed Warehousing Solutions Market Size, Share, Future Roadmap, Technological Innovations & Growth ...
    10 Oct 2020
    1
  • Underfloor heating
    Underfloor heating
    Underfloor Heating Market Challenges On Upcoming Trends 2027 | Robert Bosch GmbH, Robot uk ltd, Schneider ...
    30 Aug 2020
    1
This week's most popular news